Dr. Robert Vanzant, M.D.
What this data tells you about Dr. Vanzant
Dr. Robert Vanzant is a family medicine in Katy, TX, with 20 years in practice. Based on federal Medicare data, Dr. Vanzant performed 3,474 Medicare services across 2,909 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanzant received a total of $5,979 from 54 pharmaceutical and/or device companies across 384 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanzant is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 463 | $92 | $292 |
| Comprehensive metabolic blood panel | 394 | $10 | $31 |
| Lipid panel (cholesterol and triglycerides) | 328 | $13 | $40 |
| Annual wellness visit, follow-up | 257 | $130 | $298 |
| Hemoglobin A1c test (diabetes monitoring) | 201 | $9 | $25 |
| Advance care planning consultation, first 30 min | 185 | $77 | $188 |
| Thyroid stimulating hormone (TSH) test | 158 | $16 | $50 |
| Complete blood count (CBC) with differential | 129 | $8 | $20 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 121 | $283 | $450 |
| Flu vaccine administration | 121 | $31 | $50 |
| Flu vaccine, high-dose | 120 | $72 | $122 |
| Pneumonia vaccine administration | 119 | $31 | $50 |
| Office visit, established patient (20-29 min) | 102 | $67 | $206 |
| Annual depression screening | 97 | $19 | $43 |
| Urine microalbumin test (kidney screening) | 94 | $6 | $12 |
| Creatinine test (kidney function) | 94 | $5 | $11 |
| Prostate cancer screening; prostate specific antigen test (psa) | 79 | $19 | $40 |
| Annual alcohol misuse screening, 5 to 15 minutes | 62 | $18 | $43 |
| Drug injection, under skin or into muscle | 49 | $10 | $32 |
| Automated urinalysis | 39 | $2 | $5 |
| Administration of vaccine | 35 | $15 | $39 |
| Chest X-ray, 2 views | 28 | $27 | $79 |
| Ferritin level test (iron stores) | 27 | $13 | $28 |
| Iron level test | 27 | $6 | $25 |
| PSA test (prostate cancer screening) | 27 | $18 | $40 |
| Transferrin (iron binding protein) level | 27 | $12 | $26 |
| Electrocardiogram (EKG), 12-lead | 20 | $11 | $34 |
| Assessment of emotional or behavioral problems | 18 | $4 | $12 |
| Transitional care management services for problem of at least moderate complexity | 14 | $165 | $467 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 14 | $167 | $376 |
| Uric acid level test | 13 | $4 | $13 |
| Office visit, established patient (10-19 min) | 12 | $46 | $128 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for family medicine in TX.
Geographic Context
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vanzant is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (low-engagement, top 10%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vanzant experienced with office visit, established patient (30-39 min)?
Does Dr. Vanzant receive payments from pharmaceutical companies?
How do Dr. Vanzant's costs compare to other family medicines in Katy?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology